Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
By Felix Zeppernick, R. Ahmadi, Benito Campos, C. Dictus, B. Helmke, N. Becker, P. Lichter, A. Unterberg, B. Radlwimmer, C. Herold‐Mende. Clinical Cancer Research, 2008
630 citations recorded by the source corpus.
Subfields: Developmental Neuroscience, Genetics, Oncology
View Paper: https://www.semanticscholar.org/paper/2603c9788913440923ba6c8ee85ca4a7d4d8abdf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Developmental Neuroscience
In Oncology
Citations in the corpus
- Macrophages in Tumor Microenvironments and the Progression of Tumors (2012, background): “Several studies have reported that TAMs are always found distributed around CSCs, and the number of infiltrating TAMs has been positively correlated with the histological grade of the malignancy and the number of CSCs found [98, 99].”
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery (2009, background): “Nevertheless, a number of markers used in cell sorting are emerging as being predictive of disease progressio”